Andrew Schneider at Tanglewood Foot Specialists in Houston, TX.
The peptide still distributes systemically from a local injection, so you get both targeted and whole-body effects
A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
Rotate injection sites to prevent lipodystrophy 9 Store reconstituted solution refrigerated (28C) and use within 28 days Week 12 Initial anti-inflammatory effects begin
However, as with any treatment, there can be side effects, including: - Injection site reactions - Temporary nausea or digestive discomfort It's essential to monitor your response and keep an open line of communication with your healthcare provider throughout the process
